Our optimal conditions for distinguishing brains with AD pathology from those with cerebrovascular disease (CVD) or other pathologies, or from brains of tau knock-out (KO) mice, are those described as “AD RT-QuIC” in “Methods”. This evidence concerns the gene MAPT and cerebrovascular disorder.